Jupiter Asset Management’s Coherus Oncology CHRS Stock Holding History

Jupiter Asset Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,004	Closed	-$185K	–	512
2023 Q1	$185K	Hold	27,004	–	–	﹤0.01%	395
2022 Q4	$214K	Hold	27,004	–	–	﹤0.01%	436
2022 Q3	$260K	Hold	27,004	–	–	﹤0.01%	496
2022 Q2	$196K	Buy	+27,004	New	+$235K	﹤0.01%	555
2021 Q4	–	Sell	-137,344	Closed	-$2.21M	–	566
2021 Q3	$2.21M	Sell	137,344 -315,868	-70%	-$4.63M	0.03%	336
2021 Q2	$6.27M	Buy	453,212 +183,212	+68%	+$2.59M	0.06%	260
2021 Q1	$3.94M	Buy	270,000 +70,000	+35%	+$1.19M	0.04%	353
2020 Q4	$3.47M	Hold	200,000	–	–	0.04%	366
2020 Q3	$3.66M	Buy	+200,000	New	+$3.72M	0.04%	337

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jupiter Asset Management's CHRS Position: Q2 2023 in Review

Jupiter Asset Management sold out of Coherus Oncology (CHRS) in Q2 2023, closing a stake of 27,004 shares — an estimated $185K sold.

Jupiter Asset Management first reported a position in CHRS in Q3 2020 and held it in 9 quarters. The position peaked at $6.27M in Q2 2021. 161 funds tracked by Wall St. Rank hold CHRS as of Q2 2023.

Jupiter Asset Management reported no remaining Coherus Oncology position as of Q2 2023 after selling out during the quarter.
Jupiter Asset Management sold 27,004 Coherus Oncology shares in Q2 2023, an estimated $185K.
Jupiter Asset Management first reported a position in Coherus Oncology in Q3 2020 and held it in 9 quarters.
Jupiter Asset Management's Coherus Oncology position peaked at $6.27M in Q2 2021.
161 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2023.

Based on Jupiter Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.